Cases 21 - 30 of 38
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co., Ltd. et al v. Alkem Laboratories Ltd. et al
as 1:2019cv01213
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alkem Laboratories Ltd. et al
as 1:2018cv01738
Defendant:
Ascend Laboratories, LLC and Alkem Laboratories Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GMBH
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Pharma, Inc. et al v. Alkem Laboratories Ltd.
as 1:2018cv01014
Plaintiff:
Horizon Pharma, Inc. and Horizon Pharma USA, Inc.
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. v. Alkem Laboratories Ltd.
as 1:2018cv00972
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Insys Therapeutics, Inc. et al v. Alkem Laboratories Ltd. et al
as 1:2017cv01419
Plaintiff:
Insys Therapeutics, Inc. and Insys Development Company, Inc.
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Alkem Laboratories Ltd. et al
as 1:2017cv00850
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
